- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Posicam nets Japanese clearance
Financially troubled PET developer Positron appears to be making progress with its revival plans. The Houston-based firm has received approval from the Japanese Ministry of Health & Welfare for its Posicam-HZ Series PET scanner. The Posicam scanners
Financially troubled PET developer Positron appears to be making progress with its revival plans. The Houston-based firm has received approval from the Japanese Ministry of Health & Welfare for its Posicam-HZ Series PET scanner. The Posicam scanners will be marketed and distributed in Japan exclusively by Imatron Japan, an independent distributor in which ultrafast CT developer Imatron maintains a 24% equity stake. Imatron, of South San Francisco, CA, took over as controlling shareholder in Positron earlier this year (SCAN 2/3/99).
Upon completion of an expected major third-party equity financing deal, Positron will be well positioned to take advantage of PET market opportunities in Japan and the U.S., said Imatron CEO Lewis Meyer. Imatron hopes that the 24 Japanese customers of Imatrons ultrafast CT scanner will be interested in utilizing PET and ultrafast CT as complementary imaging modalities.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
